Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

about

Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy

P2860

Q57135103-964E094B-4A92-4416-8348-D7E5A16B3D7D

P2860

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

Item

http://www.wikidata.org/entity/Q53078776

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Supplement Use and Chemotherap ...... ial (S0221): The DELCaP Study.

@en

Supplement Use and Chemotherap ...... y in a Cooperative Group Trial

@nl

type

Item

label

Supplement Use and Chemotherap ...... ial (S0221): The DELCaP Study.

@en

Supplement Use and Chemotherap ...... y in a Cooperative Group Trial

@nl

prefLabel

Supplement Use and Chemotherap ...... ial (S0221): The DELCaP Study.

@en

Supplement Use and Chemotherap ...... y in a Cooperative Group Trial

@nl

P1476

Supplement Use and Chemotherap ...... ial (S0221): The DELCaP Study.

@en

P2093

G Thomas Budd

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Gary R Zirpoli

http://www.w3.org/2001/XMLSchema#string

Gregory Ciupak

http://www.w3.org/2001/XMLSchema#string

Halle C F Moore

http://www.w3.org/2001/XMLSchema#string

James A Stewart

http://www.w3.org/2001/XMLSchema#string

Joseph M Unger

http://www.w3.org/2001/XMLSchema#string

Julie R Gralow

http://www.w3.org/2001/XMLSchema#string

Kathy S Albain

http://www.w3.org/2001/XMLSchema#string

Lara E Sucheston-Campbell

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.

Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.

SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.

Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review.

Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer.

The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.

A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).

Supplement use during an intergroup clinical trial for breast cancer (S0221).

CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel

P31

scholarly article

P356

10.1093/JNCI/DJX098

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Christine Ambrosone

Dawn L Hershman

Claudine Isaacs

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29546345

http://www.w3.org/2001/XMLSchema#string

P932

6075365

http://www.w3.org/2001/XMLSchema#string

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

about

P2860

P2860

Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932